Key Events This Week
24 Aug: Stock opens at ₹41.67, down 1.84% amid sector challenges
25 Aug: Valuation upgrade signals renewed price attractiveness
27 Aug: Mojo Grade upgraded to Hold on improved financial trends
28 Aug: Week closes at ₹42.37, down 0.19% for the week

Medico Remedies Ltd Upgraded to Hold on Improved Valuation and Financial Trends
2026-08-27 08:26:59Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 26 August 2026. This shift reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. While the company demonstrates improving fundamentals and attractive valuation metrics, technical indicators remain mixed, warranting a cautious stance for investors.
Read full news article
Medico Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges
2026-08-25 08:01:54Medico Remedies Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating despite ongoing sector headwinds. With a current price of ₹41.67 and a micro-cap market classification, the pharmaceutical company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a more compelling investment case relative to its historical averages and peer group.
Read full news article
Medico Remedies Ltd is Rated Hold by MarketsMOJO
2026-08-20 10:10:57Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 28 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 August 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleWhen is the next results date for Medico Remedies Ltd?
2026-08-11 23:18:34The next results date for Medico Remedies Ltd is scheduled for 13 August 2026....
Read full news article
Medico Remedies Ltd is Rated Hold
2026-08-09 10:10:40Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 28 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 August 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article








